Medical Properties Trust Q3 net loss due to $82 mln impairment

Overview

• Medical Properties Trust Q3 net loss impacted by $82 mln in impairment charges

• Normalized FFO for Q3 2025 was $0.13 per share, down from $0.16 last year

• Company announces $150 mln strategic common stock repurchase program

Outlook

• Company anticipates Q4 2025 cash collections to approximate $22 mln

• MPT expects stabilized annual cash rent of $45 mln from NOR lease

• Company projects annualized cash rent to exceed $1 bln by end of 2026

Result Drivers

• CASH RENT COLLECTIONS - MPT reports increased cash rent collections to $16 mln in Q3, up from $11 mln in Q2, with expectations of $22 mln in Q4

• LEASE AGREEMENT - MPT agrees in principle to a lease with NOR Healthcare Systems for California operations, expected to stabilize annual cash rent at $45 mln

• ASSET SALES - MPT sold two facilities in Arizona for approximately $50 mln, contributing to strategic asset management

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and 4 "sell" or "strong sell"

• The average consensus recommendation for the specialized reits peer group is "buy."

• Wall Street's median 12-month price target for Medical Properties Trust Inc is $5.00, about 2.8% above its October 29 closing price of $4.86

• The stock recently traded at 71 times the next 12-month earnings vs. a P/E of 68 three months ago

Press Release:

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.